In lipoprotein glomerulopathy, the APOE ‘Chengdu’ variant (p.L173P; mature L155P) introduces a pathogenic helix-breaking proline within the LDLR-binding region [31]. This evidence concerns the gene LDLR and lipoprotein glomerulopathy.